Because of new regulatory requirements in Country X, companies that

Because of new regulatory requirements in Country X, companies that manufacture non-prescription medications must disclose all sources of components that are imported from other countries. The new regulations also specify that, for any individual component, the company must have a minimum of two different suppliers and that, for certain medications, one country cannot provide more than 70% of a single component used by that manufacturer. Such regulations are necessary in order to manage contamination risks, reduce the likelihood of financial dependencies on a single country, and safeguard the uninterrupted supply of critical medicines.

According to the passage, which of the following activities is required to be performed by a non-prescription medication manufacturer in Country X, and which is NOT permitted? Make only two selections, one in each column.

Required	Not Permitted	Activities
		Buying more than 70% of a component from one country
		Importing components from other countries
		Reporting to authorities the foreign components used
		Using a component for which only one supplier exists outside of Country X
		Manufacturing a drug whose components are all from a single supplier